AFB DIFFERENTIATION & SPECIATION BY HAIN LPA

image not found

NABL Cap Accredited 

The AFB Differentiation & Speciation by Hain LPA, Pure Culture test at Metropolis Healthcare uses the Hain Line Probe Assay (LPA) to accurately differentiate and identify Mycobacterium tuberculosis complex (MTBC) and non-tuberculous mycobacteria (NTM) from pure culture isolates. This molecular test provides rapid and precise species-level identification, enabling targeted treatment decisions. With high sensitivity and specificity, it ensures accurate TB and NTM diagnosis. Metropolis Healthcare offers advanced molecular testing and expert analysis for effective TB management and improved patient outcomes.

 

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 3,710.00

Sample Type: PURE CULTURE

Fasting Not Required


Notes: A0092

Frequently Asked Questions (FAQ's):

What is the AFB Differentiation & Speciation by Hain LPA, Pure Culture Test?
This test uses the Hain Line Probe Assay (LPA) to differentiate Mycobacterium tuberculosis complex from non-tuberculous mycobacteria in pure culture samples.

Why is this test important?
It helps in the precise identification of mycobacterial species, allowing clinicians to distinguish between TB and NTM infections for appropriate treatment planning.

Who should undergo this test?
Patients whose culture samples show growth of acid-fast bacilli (AFB) and require confirmation of the mycobacterial species should undergo this test.

How is the test performed?
DNA is extracted from the pure culture isolate and analyzed using the Hain Line Probe Assay at Metropolis Healthcare to identify the mycobacterial species.

What do the results indicate?
Results indicate whether the isolate belongs to the Mycobacterium tuberculosis complex or to non-tuberculous mycobacteria, guiding accurate diagnosis and therapy.

Are there any risks associated with the test?
The test itself is safe, as it is performed on a laboratory culture sample with no risk to the patient.

Why choose Metropolis Healthcare for this test?
Metropolis Healthcare provides precise, rapid, and reliable molecular differentiation of mycobacterial species using advanced technologies and expert laboratory analysis for effective clinical management.

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab